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ABSTRACT There is broad agreement that platelet aggregation is generally dependent on fibrinogen (Fg) binding to the
glycoprotein (GP) llb-lila receptor expressed on the activated platelet surface. We therefore compared rates and extents of
aggregation and of fibrinogen receptor expression and specific Fg binding to activated platelets, as a function of ADP con-
centration. Human citrated platelet-rich plasma (diluted 1 0-fold) was stirred with adenosine diphosphate (ADP) for 10 s or 2 min
to measure rates and extent of aggregation, respectively, determined from the decrease in the total number of particles. The
number of fibrinogen receptors and bound Fg were measured from mean fluorescence values obtained with FITC-labeled IgM
monoclonal antibody PAC1 and the IgG monoclonal antibody, 9F9, respectively, using flow cytometry as presented in part I
(Frojmovic et al., 1994). Because flow cytometric and aggregation measurements were routinely determined at room tem-
perature and 370C, respectively, we also compared and found temperature-independent initial rates of aggregation. The fraction
of platelets with fluorescence values above one critical threshold value, corresponding to maximally "activated" platelets (P*),
increased with increasing activator concentration and correlated linearly with the fraction of platelets recruited into aggregates
forADP (r> 0.9). Aggregation was not rate-limited by fibrinogen receptor expression or by Fg binding. It appears that each platelet
expresses its maximal Fg receptors at a critical ADP concentration, i.e., occupancy of ADP receptors. This, in turn, leads to
rapid Fg occupancy and capture of such "quantally activated" platelets into aggregates.
INTRODUCTION
It is widely recognized that platelet aggregation is centered
on the activation of GPIIb-IIIa into a receptor specific for
adhesive molecules like fibrinogen (Fg) and von Willebrand
Factor (vWF), which can mediate cross-bridging of platelets
(Plow and Ginsberg, 1989). In plasma, at the moderate shear
rates associated with stirred platelet suspensions, it appears
that Fg is the key adhesive protein allowing platelet-platelet
capture (Farrell et al., 1992; Goldsmith et al., 1994; Ikeda
et al., 1991; Marguerie et al., 1980; Peerschke, 1985; Plow
and Ginsberg, 1989). Qualitative descriptions abound of the
need for Fg in supporting turbidimetrically measured mac-
roaggregation (Farrell et al., 1992; Marguerie et al., 1980;
Peerschke, 1985; Plow and Ginsberg, 1989), but these stud-
ies are centered on bulk "25I-Fg or antibodies measurements
and on maximal activation. In addition, it is now widely
recognized that turbidimetric measurements cannot describe
early kinetics of microaggregation, which have been found
to have distinct functional (Frojmovic et al., 1983) and phar-
macologic (Pedvis et al., 1988) properties from macroag-
gregation measured from changes in light transmission. Re-
cent reports have also shown that activated GPIIb-IIIa
expressed in a nonplatelet environment, capable of binding
Fg, can support Ca+2/Fg-dependent aggregation (Frojmovic
et al., 1991; Gawaz et al., 1991; Sung et al., 1993); this has
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also been most recently demonstrated for purified activated
GPIIb-IIIa captured onto latex microspheres (2-6 gm di-
ameter) (Frojmovic et al., 1991). Although theory predicts
that the surface density of adhesive receptors and the rate of
ligand binding such as Fg can determine kinetics of platelet
aggregation (Bongrand, 1988), this simple analysis may be
complicated by post-Fg events required for a functional ex-
pression of Fg in actual cross-bridging of platelets (see Fig. 1
in the companion paper): these may involve (i) further con-
formational changes in the Fg occupied GPIIb-IIIa receptor
and the bound Fg (Plow and Ginsberg, 1989), (ii) cytoskele-
tal interactions associated with ADP activation (Newman
et al., 1987), (iii) receptor clustering, including preferential
concentration at surface projections (Hensler et al., 1992),
and (iv) altered affinity of Fg binding with time (Peerschke,
1992).
The dependence of rates ofmicroaggregation on bothADP
activator concentration (Frojmovic et al., 1989; Pedvis et al.,
1988) and on size-dependent platelet subpopulations (Wong
et al., 1989) have previously been reported for studies with
undiluted citrated platelet-rich (PRP). It has been reported
that the equilibrium dissociation constant, KD, for specific Fg
binding to its platelet receptor (Marguerie et al., 1980;
Niewiarowski et al., 1983; Peerschke, 1985; Plow and
Ginsberg, 1989), is in the same range as apparent "KM" val-
ues driving platelet micro- and macroaggregation, 0.1-0.5
and 1-2 p,M range, respectively (Frojmovic et al., 1989;
Pedvis et al., 1988; Wong et al., 1989). However, microag-
gregation in normal, stirred PRP occurs within seconds of
ADP addition (Frojmovic et al., 1989; Milton and Frojmovic,
1984), i.e., far removed from equilibrium conditions,
whereas Fg binding measurements using I125 Fg represent
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bulk, average measurements that do not detect platelet sub-
population behavior (Frojmovic, 1995).
We therefore sought to obtain, for the first time, data that
would allow a direct correlation between the dynamics of
GPIIb-IIIa receptor expression, Fg occupancy, platelet sub-
population responses, and actual recruitment of stirred plate-
lets into microaggregates. We therefore compared rates and
extent of aggregation with the percent of "quantally acti-
vated" platelets, P*, present in PRP (1:10) according to the
concentration of ADP used for activation as shown in
the companion paper (Frojmovic et al., 1994). We found that
the data best fit a model where increasing ADP concentra-
tions generates increasing numbers of P* that require only a
small fraction of their activated GPIIb-Illa receptors to be
filled with Fg to yield an optimal aggregation response for
the stirred suspension. The aggregation dynamics are-pre-
dicted by simple second-order kinetics for the reactive P*
platelets, in the presence of unreactive P0 platelets.
MATERIALS AND METHODS
Platelet isolation and analysis by flow cytometry
The procedures and materials used are exactly as described in the companion
paper for the flow cytometric studies (Frojmovic et al., 1994), with parallel
studies usually made on the same donor's PRP (1:10) for flow cytometry
and aggregation. Glutaraldehyde was freshly diluted in Ca2I/Mg2+-free Ty-
rode's solution from an 8% aqueous stock in sealed ampoules (Polysciences
Itk;2nc., Warrington, PA). Although samples for flow cytometry were kept
at room temperature, studies of aggregation were generally made at 370C,
with one set of comparative studies done at room temperature versus 37°C
(see Fig. 3).
Platelet aggregation by particle counting
Both the kinetics and sensitivity of platelet aggregation were determined by
measuring the change in platelet particle number per unit volume with the
Elzone resistive particle counter (Model 80XY, Particle Data Inc., Elmhurst,
IL) at various times after the addition of varying concentrations of ADP to
suspensions stirred at 1000 rpm, as previously reported (Frojmovic et al.,
1989; Wong, 1989). Counts are corrected for background (<5% of total).
The percent of platelets aggregated after a time t after addition of ADP to
the stirred platelet suspensions, %PA, was calculated using the relation
%PA = [1 - (N,INO)] X 100%, (1)
where No and N, are platelet particle counts, respectively, at times 0 and t
after ADP addition.
ADP (1-5 gl) was added by rapid injection with a microsyringe to stirred
PRP (1:10) (0.1 ml) in an aggregometry cuvette, normally at 37°C or, when
so indicated, at room temperature as used for flow cytometry studies. Sub-
sequent aggregation was arrested with the addition of 0.4 ml of 0.8% gl-
utaraldehyde to the PRP (1:10) at times, t, ranging from 0 s to 22 min after
the addition of ADP. These fixed samples were further diluted with isotonic
saline to final counts of <70 particles/,l and counted within 2 h of fixation.
Each sample was counted twice, with <5% deviations from mean values.
The initial rate and maximal extent of aggregation were typically measured
at IO s (PA1) and 2 min (PAm.), respectively. Log-dose response curves were
obtained for these two parameters for ADP varying from 0 to 100 ,uM; ADP
concentrations corresponding to half-maximal rate or extent of PA, desig-
nated as [ADP]1/2, were thus obtained.
RESULTS
Platelet aggregation
To compare fluorescence measurements to platelet aggre-
gation, studies were conducted for PRP samples diluted 1:10
with Tyrodes-albumin exactly as for the flow cytometric
studies in the companion paper (Frojmovic et al., 1994), ex-
cept that the suspensions were stirred at 1000 rpm, normally
at 37°C, after ADP addition (T = O). These studies allowed
the determination of the initial rate (PAt) and maximal extent
(PAmax) of aggregation for varying ADP concentrations (Fig.
1). A log-dose-response curve is shown for a typical donor
in Fig. 2 for PAi and PAma measured at 10 s and 2 min of
stir, respectively. We found that [ADP]1,2 for PAi (1.6 ± 0.4
,uM), and for PAm. (1.4 ± 0.6 ,uM), evaluated at 37°C for
nine donors, were not significantly different (unpaired t test,
p = 0.25). We initially chose 37°C as a more physiologic
temperature for aggregation studies. However, fibrinogen
binding and flow cytometric measurements have routinely
been conducted at room temperature (RT) (Frojmovic, 1994;
Marguerie et al., 1979, 1980; Shattil et al., 1989), even for
comparisons with turbidimetric aggregation generally done
at 370C (Marguerie et al., 1979; Shattil et al., 1989); more-
over, it has been reported that there is about one-half of the
on-rate and maximal extent of I125-Fg binding to activated
platelets at 37°C compared with RT (Marguerie and Plow,
1981; Marguerie et al., 1982; Peerschke, 1992). Therefore,
we next compared aggregation dynamics for 37°C and RT.
The data comparing platelet aggregation at room tempera-
ture (RT) versus 37°C, at two different ADP concentrations
(Fig. 3), indicate that the initial rates of platelet aggregation
are the same for both temperatures, whereas maximal extent
(PAmax at 2 min) is -33% lower at 1.5 ,uM ADP at 370C
compared with RT averaged for five donors, although similar
at 100 ,uM ADP. There was negligible reversal in aggrega-
tion between 2 and 5 min stir at 100 ,uM ADP for 370C or
RT. However, at 1.5 ,uM ADP (Fig. 3 B), PAma reached at
2 min at RT remained unchanged out to 5 min, but variable
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FIGURE 1 Dependence of the initial rate (PA) and maximal extent
(PAm.) of platelet aggregation on ADP concentration. Platelet aggregation
(PA) was determined from the change in particle count forPRP (1:10) stirred
at 1000 rpm at 37°C for increasing times after addition of varying con-
centrations of ADP. Initial slopes (.) typically obtained from PA at 10
s, and maximum extent, typically at 2 min, yield PAj and PAmx, respectively
(see Materials and Methods).
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FIGURE 2 Log-dose-response analysis for the initial rates (PAj) as well
as the maximal extent (PAm.) of platelet aggregation measured at 37°C
(shown for one typical donor). Measurements were taken after 10 s (PAt)
and 2 min (PA,,) of stirring at 1000 rpm; data were normalized to maximal
values obtained at 100 ,uM ADP.
reversal was observed at 37°C: in one of five donors there
was no reversal, but on average there was about 20%
decrease in PAmax.
Comparison of aggregation and
fibrinogen-receptor dynamics
Comparison of on-rates (v) for PAC1/9F9 with rates and
extent of aggregation
We found comparable log dose response profiles for rates
of platelet aggregation (PAt) and for initial on-rates (v)
determined for both 9F9 and PAC1 as a function of
varying ADP activator concentration, with [ADP]1/2 =
1.4 ± 0.1 ,uM (Fig. 4 A).
Comparison of maximal binding (Flmaxj of PAC1 and 9F9
with rates and extent of aggregation
a) Whole population studies
Similar ADP concentration-dependent profiles were ob-
tained for the extent of platelet aggregation (PAmax) and the
extent of both PAC1 and 9F9 maximal binding, which are
used to measure fibrinogen receptor expression and fibrino-
gen binding, respectively (Fig. 4 B). The [ADP]112 values for
the extents of platelet aggregation (PAmin), fibrinogen bind-
ing, and fibrinogen receptor expression were all approxi-
mately 1.5 ,uM (Fig. 4 B).
b) Subpopulation analysis
An analysis of mean fluorescence was done in terms of the
percentage of cells with fluorescence (Fl) above a critical
threshold (Flc). Similar log-dose-response curves were ob-
tained for parallel studies of the percentage of cells with
Fl > Flc (Fig. 5) and the percent of maximal extent of platelet
aggregation (PAmax) for varying concentrations of ADP as
predicted in the companion paper for comparisons of Flma
and %P* (Fl > Flc). Cross-plots comparing the extent of
platelet aggregation (PAm.) against the fraction of cells with
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FIGURE 3 Kinetics of platelet aggregation at 37°C versus room tem-
perature for (A) maximal (100 ,uM) and (B) intermediate (1.5 ,uM) ADP
concentrations. The same PRP (1:10) was used for the two temperatures and
ADP conditions. The data have been pooled for four donors studied in
parallel, with mean and SD bars.
fluorescence above a critical threshold demonstrate a linear
relationship between the two variables for either PAC1 (Fig.
5 A) or 9F9 binding (Fig. 5 B) with %PA generally -0.80
of %P* (percent of cells with Fl > Flc).
Dependence of rate of platelet aggregation on
initial platelet count and fibrinogen concentration
Because we observed subpopulation responses for platelet
aggregation, we needed to identify the kinetic order of
Frojmovic et al. 2071
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FIGURE 4 A comparison of the (A) rates and (B) extent of platelet ag-
gregation and PAC1/9F9 binding to platelets as a function of varying ADP
concentrations. On rates (v) and maximal fluorescence were determined as
for Fig. 7 in the companion paper, ignoring any subpopulation behavior (1),
and comparisons were made for parallel PRP samples from the same donor.
Data have been normalized to maximal values obtained for each parameter
at 100 ,uM ADP; mean values are shown at each ADP concentration, pooled
for 3 and 10 donors, respectively for A and B; SD are indicated only for
aggregation measurements (PA), because these were previously shown in
the companion paper (1) for antibody binding.
platelet aggregation with respect to initial platelet count (No)
over the range of initial platelet counts studied (-25,000-
50,000 Vl-l for PRP (1:10)). We found that aggregation was
second order, because %PAi varied linearly with No for the
range from PRP to PRP (1:10) with an essentially zero
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FIGURE 5 The maximal extent of platelet aggregation (%PA) versus the
percent of cells "quantally" transformed into the activated state (P*) as
reported by (A) FITC-PAC1 and (B) FITC-9F9. PA was measured at 2 min
stir for varying concentrations of ADP in parallel with measures of the
percent of cells with fluorescence (F1) above a critical threshold (Fl) cor-
responding to the activated platelet subpopulation (P*) as described in the
companion paper (1). The same donors were compared for PA and FH mea-
sures; actual parameter values (not normalized) are shown for seven and four
donors, respectively, for PACl and 9F9 studies. Lines drawn are the best
fits for a linear regression, with r values of 0.7 and slopes of 0.8 for both
A and B.
intercept (r = 0.99): (Fig. 6); %PA; = cNo, but expressing
the rate of aggregation as actual number of cells/unit
volume/s requires %PAi X No = (cNo)2, actually second order
kinetics. It follows that %PAi will decrease linearly as the
fraction of P* available to participate in aggregation de-
creases, assuming that "resting" P0 platelets cannot coag-
gregate with P* with any significant capture efficiency.
Because our studies were all conducted for a 10-fold di-
lution ofPRP with buffer, the Fg concentration was -0.7 ,uM
in all cases, given that normal donors have plasma Fg con-
centrations of 7.1 AM (± 0.3 ,AM for 2 SD) (Bakker et al.,
1992). We evaluated the possible rate-determining effect of
FITC-PAC1
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FIGURE 6 Dependence of the rate of platelet aggregation on initial plate-
let count (No). PRP was increasingly diluted with walsh-albumin (contain-
ing 2 mM Mg2') at 37°C and the initial rate of aggregation (PAt) measured
for stir times between 3 and 20 s, depending on No. Data shown are typical
for one of two experiments.
more physiologic Fg by adding pure Fg to PRP (1:10) to give
a final Fg concentration of 3.5 ,uM (5 X more). This is ex-
pected to increase early linear on-rates for Fg by fivefold and
affect the initial rate of aggregation (PA.) if Fg is
rate-determining. No significant effect was seen (Fig. 7).
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FIGURE 7 Dependence ofplatelet aggregation on plasma fibrinogen con-
centration. The aggregation time course is compared for free fibrinogen
concentration in PRP (1:10) of 0.7 ,AM (0) with that of a fivefold increase
in concentration (3.5 ,uM; *) obtained by addition ofpure human fibrinogen
to the PRP (1:10). Data were obtained for the same donor's PRP at 37°C.
DISCUSSION
We have found that the "quantal" transformation of "resting"
platelets (P°) to "activated" platelets (P*) by critical con-
centrations ofADP present in platelet suspensions described
in the companion paper (Frojmovic et al., 1994) determines
the dynamics of platelet microaggregation in stirred suspen-
sions. Identical log-dose-responses were obtained for PAi
and PAma as a function of activating ADP concentrations.
Thus, we found that both rates (PAj) and maximal extents of
aggregation (PAmu) varied directly and linearly with the %P*
present in PRP (1:10), determined by the [ADP] added. This
observation is most simply consistent with a model where
only those platelets that are activated, P*, (i) can participate
in platelet aggregation, (ii) do not lose their aggregability
with time, (iii) do not co-aggregate significantly with resting
platelets, P°, and (iv) follow essentially second order kinetics
with a simple dependence of PAi, expressed as percent ag-
gregation, on the number of P* present per unit volume. We
have indeed confirmed that maximally activated platelets,
P*, do follow second-order kinetics for No values down to
PRP (1:10) and below (Fig. 6); and that the rates and extent
of aggregation, previously shown not to exhibit time-
dependent refractoriness out to >10 min of incubation ofPRP
with 10 ,uM ADP (Frojmovic et al., 1983), are equally un-
affected for 10-fold diluted PRP as used in our flow
cytometry/aggregation studies (data not shown). If platelets
are not refractory to aggregation, and if the entire population
were only partially activated at intermediate ADP concen-
trations, or even if P* could coaggregate more slowly with
P0 than with other P*, we would expect lowered rates of
aggregation (PA.), but the same eventual maximal extents of
aggregation (PAm,) at lowerADP concentrations. In fact, we
observed only partial PAm. at intermediate ADP concentra-
tions, even when PA was monitored out to 15-30 min of stir
after ADP addition.
Analysis of our fluorescence data in the companion paper
as a function of platelet size (from forward scatter profiles)
indicated that the 20% most sensitive platelets (20% P*)
recruited into aggregates at the lowest ADP concentrations
contain the intermediate to largest sized platelets, with the
heterogeneity in platelet responses associated with additional
platelet parameters likely related to platelet production and
platelet age (Penington et al., 1976; Corash et al., 1977).
These findings are consistent with previous reports that
"larger" platelets isolated by elutriation (Wong et al., 1989),
by differential centrifugation (Carter and Gear, 1986) or by
aggregation (Haver and Gear, 1982), are recruited into ag-
gregates at lower ADP concentrations than are "smaller"
platelets; the considerable overlap observed in size histo-
grams for the "larger" and "smaller" populations in the latter
two methods have also suggested major roles for size-
independent heterogeneity in platelet biochemistry and ag-
gregability. On the basis of platelet functional heterogeneity,
we propose the following model for ADP concentration-
dependent activation/aggregation of platelet subpopulations.
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A simple model of occupancy of any one platelet by a
critical threshold number of ADP molecules is proposed
as a pre-requisite for "firing" an "all-or-none" expression
of GPIIb-IIIa receptors. We propose that mid-size to
larger platelets contain ADP receptors more sensitive for
coupling to activation of GPIIb-IIIa, as proposed for a
pseudo-linkage between ADP binding and GPIIb-IIIa ac-
tivation (De Cristofaro et al., 1988), rather than any het-
erogeneity in ADP receptor density or affinity (KD) for ADP
binding, which have been proposed to be 0.4 ± 0.1 ,uM with
-60,000 sites per platelet averaged for the entire platelet
population (Cattaneo et al., 1991; Jefferson et al., 1988). This
would be consistent with a report of receptor homogeneity
for thrombin binding to platelets but, in the case of thrombin,
responses only occurred for distinct platelet subpopulations
in intracellular calcium increases (Davies et al., 1990). Thus,
rapid equilibrium binding ofADP to the most sensitive plate-
lets responding to 0.4 ,uM ADP will yield 50% occupancy
or 30,000 ADP-occupied sites per platelet, predicted to "fire"
all ofthe .30,000 GPIIb-IIIa (Plow and Ginsberg, 1989) into
high affinity receptors for Fg. Less sensitive platelets would
require greater numbers of bound ADP to "fire" the GPIIb-
lIla complexes into competent receptors for Fg. Direct stud-
ies of ADP occupancy and platelet functional heterogeneity
will yield the correct details for this model.
We have previously reported that the rate of transforma-
tion of resting platelets (discocytes) to cells with one or more
pseudopods (echinocytes) generally parallels initial rates of
microaggregation for 1-10 AM ADP with an onset time for
aggregation of 1 s (Milton and Frojmovic, 1984). We have
also recently demonstrated that these pseudopods can con-
centrate GPIIb-IIIa receptors and fibrinogen on their tips
within 3 s of ADP activation, which would facilitate
pseudopod-mediated platelet aggregation (Hensler et al.,
1992). The fact that adrenaline is associated with less than
one-third of all platelets as echinocytes, with corresponding
partial aggregation, and that low ADP (0.1-0.5 AM) showed
ADP-dependent partial conversion of discocytes to echino-
cytes (Milton et al., 1980), is consistent with the idea that
activator concentration may yield only subpopulations of
shape-changed platelets and corresponding partial aggrega-
tion. Pseudopod formation and expression of fibrinogen re-
ceptors will occur maximally within seconds of ADP acti-
vation for increasing fractions of platelets with increasing
ADP addition.
Our comparison of microaggregation dynamics for RT
versus 37°C show temperature-independent initial rates of
aggregation for -50% or >80-90% conversion of resting to
activated platelets (1.5 vs. 100 ,M ADP in Fig. 3). It appears
that 50% decreases in on-rates or numbers of Fg-accessible
receptors, reported for studies at 37°C versus RT (Gawaz
et al., 1991; Marguerie and Plow, 1981; Marguerie et al.,
1982; Peerschke, 1992), do not provide any limitation on
kinetics of aggregation at 37°C versus RT. This is also con-
sistent with the observations that i) a fivefold increase in free
Fg concentration in PRP (1:10) did not alter aggregation
dynamics (Fig. 7), and ii) the apparent decrease, but not total
loss, in accessibility of the GPIIb-IIIa receptor for PAC1 or
Fg, with a latent time of about 60 s (Fig. 4 in the companion
paper) is not reflected in any loss in platelet aggregability
under conditions where PAmax is achieved within 1-2 min.
Our results using 9F9 to probe the on-rates of Fg to rapidly
expressed GPIIb-IIIa receptors on platelets demonstrate that
for PRP (1:10), associated with 0.7 ,uM free Fg in the 10-fold
diluted plasma (Bakker et al., 1992), the half-time (t,,2) for
full occupancy is on the order of 2-3 min, which we have
confirmed using FITC-labeled fibrinogen (Frojmovic, 1995),
with <20% of full Fg receptor occupancy within the 30 s of
ADP addition used for measuring rates of aggregation. This
data, along with other studies using FITC-Fg (Xia and
Frojmovic, 1994), suggest that <1-5% occupancy of Fg re-
ceptors is actually needed to provide >50% of capture effi-
ciencies for microaggregate formation. It is therefore ex-
pected that at physiologic Fg concentrations of 7 ,uM, ADP
concentrations will determine the fraction of platelets rapidly
expressing essentially all of their Fg receptors, with rates of
aggregation limited by the fraction of such P expressed, and
not limited by on-rates of Fg binding that can yield >20%
occupancy of receptors within 3 s of ADP activation (10
times faster at 7 ,uM Fg). Direct measurements of Fg receptor
occupancy and capture efficiencies have been reported as a
function of shear stresses in well defined, homogeneous
laminar flow (Xia and Frojmovic, 1994).
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